Such a Skittish Market<br />By Rev Shark<br />RealMoney.com Contributor<br />7/2/2009 8:29 AM EDT <br /><br />Those who won our independence believed liberty to be the secret of happiness and courage to be the secret of liberty. <br />-- Louis D. Brandeis<br /><br />The market will likely offer few fireworks today as market players take a break for the Independence Day holiday following one of the wildest six-month periods ever for the stock market. After hitting lows in March not seen in more than 10 years, we had one of biggest gains ever over the next few months. The mood shifted from a feeling that the world is coming to an end to celebration that the worst is over and that steady improvement lies ahead. <br /><br />We haven't made much additional progress over the last couple of months, but the stock market has been enjoying a steady diet of optimism even though many on Main Street don't believe that things are really getting that much better. <br /><br />I continue to be surprised by how the attitude of people I talk to about the economy is much less upbeat than what the stock market seems to be reflecting. The business media is full of stories about "green shoots" and how things aren't quite as bad as they were. The market has embraced that feeling and has plugged away nicely for a number of months, but the folks I tend to encounter feel much more worried and less positive. <br /><br />Part of the explanation is that the market is supposed to look forward and discount developments down the road. The way the market is acting, the recovery is right around the corner and should be relatively smooth. <br /><br />The question is whether we can trust the market's judgment. The market was horribly wrong in April and May of 2008 and did a terrible job of predicting what lay ahead for both the economy and the stock market. If you took action as we began to falter after that time you were OK, but if you blindly stuck to the argument that the market was making positive predictions back in May 2008, you were in big trouble six months later. <br /><br />The market is not a good predictor of where things are going to be months from now, but it does give us warning of how trends may be shifting. We need to stay highly responsive to that and adapt as things change. Good action last month may be negated very quickly by poor action this month. The idea isn't to embrace just the things we like, but to look at the big picture and to react as developments emerge. <br /><br />The market has not giving us any major warnings yet, but it has been struggling a little more. We have had some upside over the past week or so with the end of the quarter, index rebalancing and the inflow of new money for the second half of the year, but we haven't been able to gain any strong traction. On the other hand, we are still holding support levels and the bears can't gain much ground either. <br /><br />Today we have the jobs report and what will be very thin trading, so it's going to be tough to draw any major conclusions. Still, the reversal yesterday and the end of some artificial factors that have held us up should make us increase our caution levels. We'll see how we react to the jobs data, but right now the market is a bit nervous. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />M&A news: IPCR +6.8% (Flagstone Reinsurance offers to acquire all of IPC's outstanding shares for total consideration of ~$33.62/share; also Validus reaffirms commitment to outstanding IPC offer), NRG +1.0% (Exelon increases offer to acquire NRG Energy by 12.4%)... Other news: ELN +27.1% (Johnson & Johnson announce definitive agreement for Alzheimer's immunotherapy program and equity investment), DAC +10.7% (announces it has reached agreement on waiver terms on all its credit facilities), JMBA +8.1% (announces multi-unit restaurant sale as part of broader refranchising strategy), QSFT +7.0% (will replace Wind River Systems in the S&P MidCap 400), PACR +6.3% (enters first amendment and waiver to its credit agreement), AIG +2.9% (in agreement to sell its consumer finance operations in Colombia),REP +2.2% (confirms it has received offers for YPF - DJ), DEO +2.2% (issues statement regarding the new Captain Morgan rum facility in the US Virgin Islands)... Analyst comments: ESLR +9.3% (upgraded to Overweight from Underweight at JP Morgan), DAL +7.7% (initiated with Overweight at Morgan Stanley), ENER +4.7% (initiated with Overweight at JPMorgan), CAL +3.9% (upgraded to Overweight at Morgan Stanley). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: ILMN -13.4%, MANH -9.1%, XLNX -5.2%, DMAN -2.5% (light volume)... Select metals/mining names showing weakness: HMY -5.3%, GFI -4.3%, AAUK -3.7%, KGC -3.3%, AU -3.3%, AUY -3.2%, GG -3.0%, AEM -2.7%, GOLD -2.3%, MT -2.0%, SLV -1.8%, VALE -1.6%, BBL -1.5%, GLD -1.4%... Select oil/gas names trading lower: RDS.A -3.0%, SLB -2.0%, TOT -1.9%, COP -1.7%, PTR -1.6%, E -1.4%... Select drug related names ticking lower: GSK -2.7%, WYE -2.1%, AZN -1.8%, SHPGY -1.5%, NVS -1.1%... Select financials showing weakness: AXA -4.4%, IRE -3.3% (Moody's downgrades Ireland to Aa1; outlook negative), CS -2.6%, ING -2.3%, ABB -2.3%, UBS -2.1%, MS -1.9%, BAC -1.7%, WFC -1.5%, DB -1.3%... Select telecom related names trading lower: CHU -3.8%, CHL -3.4%, VOD -2.5%... Other news: DSCO -51.4% (learned that the FDA will now apply a newly-defined standard to determine whether Discovery Labs has adequately demonstrated comparability of Surfaxin clinical to commercial drug product; also downgraded to Sell at Wedbush Morgan) LEA -20.8% (Reaches agreement in principle on consensual debt restructuring; plans to commence proposed restructuring under Chapter 11), TIVO -16.0% (announces that U.S. Court of Appeals for the Federal Circuit granted the request of EchoStar and its related companies to stay the contempt order), SEPR -15.6% (determined that SEP-225289 did not meet the primary efficacy endpoint; the positive control in the study did achieve separation from placebo that was statistically significant on the primary endpoint), LIFE -5.3% (trading down in sympathy with ILMN), ACUR -4.9% and KG -3.1% (Acura Pharma and King Receive FDA Complete Response Letter Regarding Acurox)... Analyst comments: DYN -5.7% (downgraded to Sell at UBS), LUV -4.4% (downgraded to Underweight at Morgan Stanley), JCI -2.7% (downgraded to Hold at Deutsche), FSLR -2.4% (downgraded to Neutral at JPMorgan).